This page shows results related to Alaway and Eyelid Oedema from the FDA Adverse Event Reporting System (AERS). The adverse event Eyelid Oedema has been reported to the FDA a total of 16 times for Alaway.
Learn More About Alaway Adverse EventsThe Proportional Reporting Ratio (PRR) for Alaway and Eyelid Oedema is 46. The chart below compares this proportional reporting ratio of Eyelid Oedema for drugs used in similar therapies to Alaway. The higher the proportional reporting ratio is, the more likely a drug is associated with Eyelid Oedema.
| Eyelid Oedema | |
| Alaway | 46 |
NOTE: The PRR metric is still in Beta testing by DrugCite and is intended for use by researchers only.
Of those reporting Eyelid Oedema, why were they taking Alaway?
| Eye Pruritus | 5 |
| Eye Allergy | 4 |
| Seasonal Allergy | 2 |
| Drug Use For Unknown Indication | 1 |
| Hypersensitivity | 1 |
| Allergy To Animal | 1 |
 Show More |
Which medications reported to the FDA are most commonly associated with Eyelid Oedema?
| Latisse | 248 |
| Gleevec | 242 |
| Botox Cosmetic | 180 |
| Lyrica | 148 |
| Humira | 99 |
| Enbrel | 97 |
| Xalatan | 89 |
| Restasis | 71 |
| Zometa | 65 |
| Remicade | 65 |
| Augmentin 125 | 57 |
| Show More |
